In this systematic review, we used the second stage of this methodology [12] to assess the evidence for: (1) the effect of intervening to reduce body fatness on biomarkers in the insulin signalling pathway; and (2) the effect of biomarkers in the insuling signalling pathway on prostate cancer risk. This evidence concerns the gene INS and prostate carcinoma.